BACKGROUND: Data supporting the efficacy of condoms against human papillomavirus (HPV) infection in males are limited. Therefore, we examined the effect of consistent condom use on genital HPV acquisition and duration of infection. METHODS: A prospective analysis was conducted within the HPV Infection in Men Study, a multinational HPV cohort study. Men who were recently sexually active (n = 3323) were stratified on the basis of sexual risk behaviors and partnerships. Using Cox proportional hazards regression, type-specific incidence of HPV infection and clearance were modeled for each risk group to assess independent associations with condom use. RESULTS: The risk of HPV acquisition was 2-fold lower among men with no steady sex partner who always used condoms, compared with those who never used condoms (hazard ratio, 0.54), after adjustment for country, age, race, education duration, smoking, alcohol, and number of recent sex partners. The probability of clearing an oncogenic HPV infection was 30% higher among nonmonogamous men who always used condoms with nonsteady sex partners, compared with men who never used condoms (hazard ratio, 1.29), after adjustment for country, age, race, education duration, marital status, smoking, alcohol, and number of recent sex partners. No protective effects of condom use were observed among monogamous men. CONCLUSIONS: Condoms should be promoted in combination with HPV vaccination to prevent HPV infection in men.
BACKGROUND: Data supporting the efficacy of condoms against human papillomavirus (HPV) infection in males are limited. Therefore, we examined the effect of consistent condom use on genital HPV acquisition and duration of infection. METHODS: A prospective analysis was conducted within the HPV Infection in Men Study, a multinational HPV cohort study. Men who were recently sexually active (n = 3323) were stratified on the basis of sexual risk behaviors and partnerships. Using Cox proportional hazards regression, type-specific incidence of HPV infection and clearance were modeled for each risk group to assess independent associations with condom use. RESULTS: The risk of HPV acquisition was 2-fold lower among men with no steady sex partner who always used condoms, compared with those who never used condoms (hazard ratio, 0.54), after adjustment for country, age, race, education duration, smoking, alcohol, and number of recent sex partners. The probability of clearing an oncogenic HPV infection was 30% higher among nonmonogamous men who always used condoms with nonsteady sex partners, compared with men who never used condoms (hazard ratio, 1.29), after adjustment for country, age, race, education duration, marital status, smoking, alcohol, and number of recent sex partners. No protective effects of condom use were observed among monogamous men. CONCLUSIONS: Condoms should be promoted in combination with HPV vaccination to prevent HPV infection in men.
Entities:
Keywords:
HIM Study; cohort study; condoms; human papillomavirus; males
Authors: Rachel L Winer; James P Hughes; Qinghua Feng; Sandra O'Reilly; Nancy B Kiviat; King K Holmes; Laura A Koutsky Journal: N Engl J Med Date: 2006-06-22 Impact factor: 91.245
Authors: Kimberly K Repp; Carrie M Nielson; Rongwei Fu; Sean Schafer; Eduardo Lazcano-Ponce; Jorge Salmerón; Manuel Quiterio; Luisa L Villa; Anna R Giuliano Journal: J Infect Dis Date: 2012-03-06 Impact factor: 5.226
Authors: Susanne Krüger Kjaer; Christian Munk; Jeanette Falck Winther; Hans Ole Jørgensen; Chris J L M Meijer; Adriaan J C van den Brule Journal: Cancer Epidemiol Biomarkers Prev Date: 2005-06 Impact factor: 4.254
Authors: Susie B Baldwin; Danelle R Wallace; Mary R Papenfuss; Martha Abrahamsen; Linda C Vaught; Anna R Giuliano Journal: Sex Transm Dis Date: 2004-10 Impact factor: 2.830
Authors: M Hippeläinen; S Syrjänen; M Hippeläinen; H Koskela; J Pulkkinen; S Saarikoski; K Syrjänen Journal: Sex Transm Dis Date: 1993 Nov-Dec Impact factor: 2.830
Authors: M C G Bleeker; J Berkhof; C J A Hogewoning; F J Voorhorst; A J C van den Brule; T M Starink; P J F Snijders; C J L M Meijer Journal: Br J Cancer Date: 2005-04-25 Impact factor: 7.640
Authors: Maarten F Schim van der Loeff; Alex Vorsters; Elske Marra; Pierre Van Damme; Arjan Hogewoning Journal: Hum Vaccin Immunother Date: 2019-05-07 Impact factor: 3.452
Authors: Alejandra J Portillo-Romero; Betania Allen-Leigh; Alan G Nyitray; Martha Carnalla; Jorge Salmerón; Leith León-Maldonado; Elsa Yunes; Leonor Rivera; Carlos Magis-Rodríguez; Galileo Vargas; Anna R Giuliano; Eiberth A Esquivel-Ocampo; Eduardo Lazcano-Ponce Journal: Transgend Health Date: 2021-12-02
Authors: Frederik Tilmann von Rosen; Antonella Juline von Rosen; Falk Müller-Riemenschneider; Inken Damberg; Peter Tinnemann Journal: Int J Environ Res Public Health Date: 2018-01-10 Impact factor: 3.390
Authors: Brandon Brown; Jerome T Galea; Gita Byraiah; Tonia Poteat; Segundo R Leon; Gino Calvo; Hugo Sánchez; Thomas Coates; Jeffrey D Klausner Journal: Transgend Health Date: 2016-05-01